Individuals
Businesses
Company
Intelligence
News
African Capital Markets
EnglishEnglish
share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram

Syndicate Bio, Sophia Genetics to improve access to cancer diagnostics

Daba Finance/Syndicate Bio, Sophia Genetics to improve access to cancer diagnostics
STARTUP VENTURE CAPITALMay 12, 2024 at 5:49 PM UTC

TLDR

  • Syndicate Bio partners with Sophia Genetics to offer comprehensive genomic profiling and liquid biopsy services in Africa.
  • The partnership marks a milestone in Africa's healthcare sector, providing advanced genomic technologies to patients continent-wide.
  • Utilizing Sophia Genetics' cloud-based solutions, Syndicate Bio aims to democratize genetic testing, improving healthcare outcomes and accessibility.

Nigeria-based biotechnology startup, Syndicate Bio, has partnered with Sophia Genetics, a cloud-native software firm specializing in data-driven medicine. This positions Syndicate Bio, founded by ex-54gene CEO, as the first laboratory in Africa to provide comprehensive genomic profiling and liquid biopsy services on a continent-wide scale.

The partnership signifies a significant milestone in Africa’s healthcare sector, offering unparalleled access to state-of-the-art genomic technologies that were previously inaccessible to patients across the continent.

Utilizing Sophia Genetics’ proficiency in cloud-based healthcare solutions, Syndicate Bio aims to democratize genetic testing and equip healthcare providers with advanced diagnostic capabilities, thereby enhancing healthcare outcomes and accessibility.

Key Takeaways

In February 2023, the World Health Organization (WHO) verified that Africa annually experiences 1.1 million new cancer cases, resulting in approximately 700,000 deaths. Data projections further suggest that without urgent and decisive interventions, cancer mortality rates in Africa could escalate dramatically to nearly one million deaths per year by 2030. These alarming statistics underscore the critical need for proactive measures to address the growing cancer burden on the continent, emphasizing the importance of initiatives like Syndicate Bio's partnership with SophiaGenetics to advance diagnostic capabilities and improve healthcare outcomes.

Syndicate Bio
Sophia Genetics
54gene
Healthtech
Cancer Diagnostics
Nigeria
Startups
Partnerships

Think someone else should see this?

share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram
Stay informed with our newsletters read by 25,000+ professionals worldwide
Newsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companies

Next Frontier

Stay up to date on major news and events in African markets. Delivered weekly.

Pulse54

UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.

Events

Sign up to stay informed about our regular webinars, product launches, and exhibitions.

+25k investors have already subscribed

To invest in this opportunity and other opportunities across Africa

Download the daba finance app on your mobile through
appstore iconappstore icon
Phone Image

Take action.

Download app

Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.

Partner with us

Unlock exciting business opportunities and growth potential.

Join Daba

Become a part of our vibrant community and enjoy exclusive benefits.

Contact us

Reach out to us for inquiries, support, or collaboration.
For Investor
StrategiesPortfolio ManagementAfrican Capital MarketsNews
Daba Pro Intelligence
For Capital Seekers
For StartupsFor Fund ManagersFor Private CompaniesFor Lenders
For Partners
Commercial BanksBroker DealersAsset ManagersInvestment BanksInvestment Advisors and ConsultantsLenders and Microfinance
Company
About UsMarket UpdatesEventsBlog and PodcastNewsletterCase StudiesAffiliate ProgramInvesting GlossaryOfficial ContactsTrust, Compliance and SecurityFrequently Asked Questions

Terms & ConditionsPrivacy Policy
EnglishEnglish

Owned by Daba Markets Inc. By using this site, you accept our Terms and Conditions and Privacy Policy. © 2024 All rights reserved. 2025 All rights reserved